Your browser doesn't support javascript.
loading
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome.
Pavan, Alberto; Bragadin, Andrea Boscolo; Calvetti, Lorenzo; Ferro, Alessandra; Zulato, Elisabetta; Attili, Ilaria; Nardo, Giorgia; Dal Maso, Alessandro; Frega, Stefano; Menin, Andrea Giovanni; Fassan, Matteo; Calabrese, Fiorella; Pasello, Giulia; Guarneri, Valentina; Aprile, Giuseppe; Conte, PierFranco; Rosell, Rafael; Indraccolo, Stefano; Bonanno, Laura.
Afiliação
  • Pavan A; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Bragadin AB; Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italy.
  • Calvetti L; Department of Oncology, San Bortolo General Hospital, ULSS8 Berica - East District, Vicenza, Italy.
  • Ferro A; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Zulato E; Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italy.
  • Attili I; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Nardo G; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Dal Maso A; Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italy.
  • Frega S; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Menin AG; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Fassan M; Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italy.
  • Calabrese F; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Pasello G; Department of Pathology, San Bortolo General Hospital, ULSS8 Berica - East District, Vicenza, Italy.
  • Guarneri V; Department of Medicine, Surgical Pathology and Cytopathology Unit, Università degli Studi di Padova, Padova, Italy.
  • Aprile G; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Università degli Studi di Padova, Padova, Italy.
  • Conte P; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Rosell R; Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
  • Indraccolo S; Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italy.
  • Bonanno L; Department of Oncology, San Bortolo General Hospital, ULSS8 Berica - East District, Vicenza, Italy.
Transl Lung Cancer Res ; 10(1): 202-220, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33569305
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article